Search Count: 14
 |
Identification Of Ampd2 Allosteric Inhibitors With Novel Mechanism Of Action By Fragment Merging Approach
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2026-06-17 Classification: METAL BINDING PROTEIN Ligands: ZN, PO4, ES9, SO4 |
 |
Optimization Efforts For Identification Of Novel Highly Potent Keap1-Nrf2 Protein-Protein Interaction Ihhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.32 Å Release Date: 2024-05-22 Classification: PEPTIDE BINDING PROTEIN Ligands: A1LVB, ACT, SO4 |
 |
Optimization Efforts For Identification Of Novel Highly Potent Keap1-Nrf2 Protein-Protein Interaction (Ppi) Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.42 Å Release Date: 2024-05-22 Classification: PEPTIDE BINDING PROTEIN Ligands: A1LVC, ACT, SO4 |
 |
Vascular Endothelial Protein Tyrosine Phosphatase In Complex With Cpd-1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2024-02-28 Classification: HYDROLASE Ligands: EDO, U7C, EPE |
 |
Vascular Endothelial Protein Tyrosine Phosphatase In Complex With Cpd-2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2024-02-28 Classification: HYDROLASE Ligands: U7L, EDO, EPE |
 |
Methyl And Fluorine Effects In Novel Orally Bioavailable Keap1/Nrf2 Ppi Inhibitor For Treatment Of Chronic Kidney Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2023-06-14 Classification: PEPTIDE BINDING PROTEIN Ligands: SGO, DTT, SO4 |
 |
Methyl And Fluorine Effects In Novel Orally Bioavailable Keap1/Nrf2 Ppi Inhibitor For Treatment Of Chronic Kidney Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2023-06-14 Classification: PEPTIDE BINDING PROTEIN Ligands: SIU, SO4 |
 |
Methyl And Fluorine Effects In Novel Orally Bioavailable Keap1/Nrf2 Ppi Inhibitor For Treatment Of Chronic Kidney Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.48 Å Release Date: 2023-06-14 Classification: PEPTIDE BINDING PROTEIN Ligands: T6I, SO4 |
 |
Crystal Structure Of Human Pyruvate Dehydrogenase Kinase 2 In Complex With Compound 1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.34 Å Release Date: 2021-08-04 Classification: TRANSFERASE/INHIBITOR Ligands: CL, ACT, DMS, W6P |
 |
Crystal Structure Of Human Pyruvate Dehydrogenase Kinase 2 In Complex With Compound 2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2021-08-04 Classification: TRANSFERASE Ligands: CL, ACT, DMS, 42A |
 |
Crystal Structure Of Human Pyruvate Dehydrogenase Kinase 4 In Complex With Compound 1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2021-08-04 Classification: TRANSFERASE Ligands: SO4, W6P |
 |
Crystal Structure Of Human Pyruvate Dehydrogenase Kinase 4 In Complex With Compound 2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2021-08-04 Classification: TRANSFERASE Ligands: SO4, 42A, MG, ADP |
 |
Crystal Structure Of Human Pyruvate Dehydrogenase Kinase 4 In Complex With Compound 7
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2021-08-04 Classification: TRANSFERASE Ligands: SO4, J0L, MG, ADP |
 |
Crystal Structure Of Human Pyruvate Dehydrogenase Kinase 2 In Complex With Compound 13
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2021-08-04 Classification: TRANSFERASE Ligands: CL, ACT, DMS, J0F |